FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1490395945> ?p ?o ?g. }

• W1490395945 endingPage "747" @default.
• W1490395945 startingPage "739" @default.
• W1490395945 abstract "We examined the diagnostic performance of serum myoglobin, creatine-kinase-MB (CK-MB) and cardiac troponin-I (cTnI) for predicting the infarct-related artery (IRA) patency in patients receiving TNK-tissue plasminogen activator (TNK-tPA) therapy for acute myocardial infarction (AMI) in the Thrombolysis in Myocardial Infarction (TIMI) 10B trial.A reliable noninvasive serum marker of IRA patency is desired to permit early identification of patients with a patent IRA after thrombolysis.We measured myoglobin, CK-MB and cTnI concentrations in sera obtained just before thrombolysis (T0) and 60 min later (T60) in 442 patients given TNK-tPA and who underwent coronary angiography at 60 min.Angiography at 60 min showed a patent IRA (TIMI flow grade 2, 3) in 344 and occluded IRA (TIMI flow grade 0, 1) in 98 patients. The median serum T60 concentration, the ratio of the T60 and T0 serum concentration (60-min ratio) and the slope of increase over 60 min for each serum marker were significantly higher in patients with patent arteries compared with patients with occluded arteries. The area under the receiver-operating characteristic (ROC) curve for diagnosis of occlusion was 0.71, 0.70 and 0.71 for the 60-min ratio of myoglobin, cTnI and CKMB, respectively. The 60-min ratios of > or =4.0 for myoglobin, > or =3.3 for CK-MB and > or =2.0 for cTnI yielded a probability of patency of 90%, 88% and 87%, respectively.The diagnostic performance of serum myoglobin, CK-MB and cardiac troponin-I (cTnI) 60-min ratios was similar. The probability of a patent IRA was very high (90%) in patients with 60-min myoglobin ratio > or =4.0, and early invasive interventions to establish IRA patency may not be necessary in this group. Serum marker determinations at baseline and 60-min after thrombolysis may permit rapid triage of patients receiving thrombolytic therapy by ruling out IRA occlusion." @default.
• W1490395945 created "2016-06-24" @default.
• W1490395945 creator A5014287819 @default.
• W1490395945 creator A5019612250 @default.
• W1490395945 creator A5026602252 @default.
• W1490395945 creator A5032606570 @default.
• W1490395945 creator A5035197495 @default.
• W1490395945 creator A5043533532 @default.
• W1490395945 creator A5056019624 @default.
• W1490395945 creator A5056910382 @default.
• W1490395945 creator A5077369190 @default.
• W1490395945 date "1999-09-01" @default.
• W1490395945 modified "2023-09-26" @default.
• W1490395945 title "Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction" @default.
• W1490395945 cites W148380574 @default.
• W1490395945 cites W1596397105 @default.
• W1490395945 cites W1821067154 @default.
• W1490395945 cites W1910307043 @default.
• W1490395945 cites W1976318744 @default.
• W1490395945 cites W1978158736 @default.
• W1490395945 cites W1982474804 @default.
• W1490395945 cites W1988226103 @default.
• W1490395945 cites W1989864566 @default.
• W1490395945 cites W1992062235 @default.
• W1490395945 cites W1994387347 @default.
• W1490395945 cites W2000401268 @default.
• W1490395945 cites W2000590077 @default.
• W1490395945 cites W2023023486 @default.
• W1490395945 cites W2026091186 @default.
• W1490395945 cites W2039422502 @default.
• W1490395945 cites W2046145599 @default.
• W1490395945 cites W2054648577 @default.
• W1490395945 cites W2055992885 @default.
• W1490395945 cites W2069680463 @default.
• W1490395945 cites W2076293145 @default.
• W1490395945 cites W2090131529 @default.
• W1490395945 cites W2092362929 @default.
• W1490395945 cites W2095945941 @default.
• W1490395945 cites W2112911632 @default.
• W1490395945 cites W2128448002 @default.
• W1490395945 cites W2136306065 @default.
• W1490395945 cites W2136754185 @default.
• W1490395945 cites W2157825442 @default.
• W1490395945 cites W2158850285 @default.
• W1490395945 cites W2160187401 @default.
• W1490395945 cites W2163593130 @default.
• W1490395945 cites W2166996547 @default.
• W1490395945 cites W2243782272 @default.
• W1490395945 cites W2267686248 @default.
• W1490395945 cites W2327567334 @default.
• W1490395945 cites W2333333837 @default.
• W1490395945 cites W3025057188 @default.
• W1490395945 cites W4235858444 @default.
• W1490395945 doi "https://doi.org/10.1016/s0735-1097(99)00274-0" @default.
• W1490395945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10483955" @default.
• W1490395945 hasPublicationYear "1999" @default.
• W1490395945 type Work @default.
• W1490395945 sameAs 1490395945 @default.
• W1490395945 citedByCount "64" @default.
• W1490395945 countsByYear W14903959452012 @default.
• W1490395945 countsByYear W14903959452015 @default.
• W1490395945 countsByYear W14903959452016 @default.
• W1490395945 countsByYear W14903959452021 @default.
• W1490395945 countsByYear W14903959452022 @default.
• W1490395945 crossrefType "journal-article" @default.
• W1490395945 hasAuthorship W1490395945A5014287819 @default.
• W1490395945 hasAuthorship W1490395945A5019612250 @default.
• W1490395945 hasAuthorship W1490395945A5026602252 @default.
• W1490395945 hasAuthorship W1490395945A5032606570 @default.
• W1490395945 hasAuthorship W1490395945A5035197495 @default.
• W1490395945 hasAuthorship W1490395945A5043533532 @default.
• W1490395945 hasAuthorship W1490395945A5056019624 @default.
• W1490395945 hasAuthorship W1490395945A5056910382 @default.
• W1490395945 hasAuthorship W1490395945A5077369190 @default.
• W1490395945 hasConcept C115725540 @default.
• W1490395945 hasConcept C126322002 @default.
• W1490395945 hasConcept C144469398 @default.
• W1490395945 hasConcept C164705383 @default.
• W1490395945 hasConcept C178790620 @default.
• W1490395945 hasConcept C185592680 @default.
• W1490395945 hasConcept C2777995511 @default.
• W1490395945 hasConcept C2778063876 @default.
• W1490395945 hasConcept C2779581417 @default.
• W1490395945 hasConcept C36036425 @default.
• W1490395945 hasConcept C36880943 @default.
• W1490395945 hasConcept C500558357 @default.
• W1490395945 hasConcept C71924100 @default.
• W1490395945 hasConceptScore W1490395945C115725540 @default.
• W1490395945 hasConceptScore W1490395945C126322002 @default.
• W1490395945 hasConceptScore W1490395945C144469398 @default.
• W1490395945 hasConceptScore W1490395945C164705383 @default.
• W1490395945 hasConceptScore W1490395945C178790620 @default.
• W1490395945 hasConceptScore W1490395945C185592680 @default.
• W1490395945 hasConceptScore W1490395945C2777995511 @default.
• W1490395945 hasConceptScore W1490395945C2778063876 @default.
• W1490395945 hasConceptScore W1490395945C2779581417 @default.
• W1490395945 hasConceptScore W1490395945C36036425 @default.
• W1490395945 hasConceptScore W1490395945C36880943 @default.

• next